project id: TCGA-BRCA; case submitter id: TCGA-B6-A40B; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.5; age at index: 76; days to birth: -27811; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1929; age at diagnosis: 27811; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage I; ajcc pathologic t: T1b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3152.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8520/3; primary diagnosis: Lobular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 10.0; composition: Not Reported; days to collection: 2467; initial weight: 10.0; sample id: efddcf44-ac69-436a-ba29-261e8dc6ad55; sample submitter id: TCGA-B6-A40B-01A; portion id: 473c05d5-4e10-41a8-a773-30131892080c; portion submitter id: TCGA-B6-A40B-01A-11; slide id: 5b2b3c90-f8e8-4853-b1f8-1cee52253550; slide submitter id: TCGA-B6-A40B-01A-01-TS1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; section location: TOP;